Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.

Abstract

BACKGROUND:

To determine the added value of preoperative prostate multiparametric MRI (mpMRI) supplementary to clinical variables and their role in predicting post prostatectomy adverse findings and biochemically recurrent cancer (BCR).

METHODS:

All consecutive patients treated at HUS Helsinki University Hospital with robot assisted radical prostatectomy (RALP) between 2014 and 2015 were included in the analysis. The mpMRI data, clinical variables, histopathological characteristics, and follow-up information were collected. Study end-points were adverse RALP findings: extraprostatic extension, seminal vesicle invasion, lymph node involvement, and BCR. The Memorial Sloan Kettering Cancer Center (MSKCC) nomogram, Cancer of the Prostate Risk Assessment (CAPRA) score and the Partin score were combined with any adverse findings at mpMRI. Predictive accuracy for adverse RALP findings by the regression models was estimated before and after the addition of MRI results. Logistic regression, area under curve (AUC), decision curve analyses, Kaplan-Meier survival curves and Cox proportional hazard models were used.

RESULTS:

Preoperative mpMRI data from 387 patients were available for analysis. Clinical variables alone, MSKCC nomogram or Partin tables were outperformed by models with mpMRI for the prediction of any adverse finding at RP. AUC for clinical parameters versus clinical parameters and mpMRI variables were 0.77 versus 0.82 for any adverse finding. For MSKCC nomogram versus MSKCC nomogram and mpMRI variables the AUCs were 0.71 and 0.78 for any adverse finding. For Partin tables versus Partin tables and mpMRI variables the AUCs were 0.62 and 0.73 for any adverse finding. In survival analysis, mpMRI-projected adverse RP findings stratify CAPRA and MSKCC high-risk patients into groups with distinct probability for BCR.

CONCLUSIONS:

Preoperative mpMRI improves the predictive value of commonly used clinical variables for pathological stage at RP and time to BCR. mpMRI is available for risk stratification prebiopsy, and should be considered as additional source of information to the standard predictive nomograms.

• Authors: Kevin Sandeman, Juho T Eineluoto, Joona Pohjonen, Andrew Erickson, Tuomas P Kilpeläinen, Petrus Järvinen, Henrikki Santti, Anssi Petas, Mika Matikainen, Suvi Marjasuo, Anu Kenttämies, Tuomas Mirtti, Antti Rannikko
• Journal: PloS one (PLoS One) Vol. 15 Issue 7 Pg. e0235779 ( 2020) ISSN: 1932-6203 [Electronic] United States
• PMID: 32645056 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Topics

• Aged
• Humans
• Magnetic Resonance Imaging
• Male
• Middle Aged
• Neoplasm Recurrence, Local (diagnosis, diagnostic imaging)
• Nomograms
• Preoperative Care
• Prognosis
• Prostate (diagnostic imaging, surgery)
• Prostatectomy
• Prostatic Neoplasms (diagnosis, diagnostic imaging, surgery)
• Risk Assessment